• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Completed Consultations on Bioengineered Foods

  • Print
  • Share
  • E-mail

BNF No. 121

Return to Listing
Submission Date:  29-OCT-09
Developer Name:  Monsanto Company
Developer Contact Information:  800 North Lindbergh Boulevard
St. Louis, Missouri 63167
Intended Use:  For use in human food and animal feed
Food:  Soybean
Intended Effect:  Increased levels of oleic acid and reduced levels of linoleic, palmitic, and stearic acid
Gene, Gene Product, or Gene Fragment:  Gene segments from fatb1-a (gene encoding fatty acid acyl carrier protein thioesterase) and fad2-1a (gene encoding fatty acid desaturase) expressed as dsRNA to induce RNAi-based suppression of the endogenous genes
Source:  Soybean
Designation:  MON 87705 (MON-877Ø5-6)
Contains a Plant-Incorporated Protectant?  N
FDA Letter Date (select to view):  01/20/2011
FDA Memo Date (select to view):  01/14/2011